35 - GenAI's Legal Challenge | Investors Questioning VC Valuations | Lilly Going Direct to Consumers | Elevance Adds Large Infusion Service

Welcome to the first episode of 2024! In this episode, we are addressing the following topics and more:

• GenAI's Legal Challenge
• Investors Questioning VC Valuations
• Lilly Going Direct to Consumers
• Elevance Adds Large Infusion Service
• Secret to Longevity & Happiness

Please check out our Episode Resources below:

------🔎RESOURCES🔎

Things are about to get a lot worse for Generative AI (Substack: Marcus on AI) // https://bit.ly/47onyV6

Goldman Sachs Raises $650 Million for Life-Sciences Bets (WSJ) // https://on.wsj.com/3TW6q65

LPs Doubt Venture Funds’ Startup Valuations (WSJ) // https://bit.ly/41O9O4C

Japanese Investors Return to Overseas Real Estate With Lessons From the 1990s (WSJ) // https://on.wsj.com/3H74lfZ

A fix for the coming physician shortage (FreeOpp) // https://bit.ly/3vkFhiG

Elevance Health to Acquire Paragon Healthcare (Press Release) // https://bit.ly/48ImFaL

Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect™ (Press Release) // https://prn.to/3RN6dze

How to Work—and Love It—Into Your 80s and Beyond (WSJ) // https://on.wsj.com/48mDOa9

------🔔SIGN UP FOR EPISODE NOTIFICATIONS🔔

https://www.podpage.com/healthfurther/

------📱FOLLOW HEALTH:FURTHER SOCIA

HF Site

YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK